Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer

D. Kilmartin, M. O'Loughlin, X. Andreu, Z. Bagó-Horváth, S. Bianchi, E. Chmielik, G. Cserni, P. Figueiredo, G. Floris, MP. Foschini, A. Kovács, P. Heikkilä, J. Kulka, AV. Laenkholm, I. Liepniece-Karele, C. Marchiò, E. Provenzano, P. Regitnig, A....

. 2021 ; 13 (17) : . [pub] 20210831

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21024037

Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score cases in a reproducibility study. This study aimed to evaluate the reproducibility of sTILs assessment using this scoring aid in cases from routine practice and to explore the potential of the tool to overcome variability in scoring. Twenty-three breast pathologists scored sTILs in digitized slides of 49 TNBC biopsies using the scoring aid. Subsequently, fields of view (FOV) from each case were selected by one pathologist and scored by the group using the tool. Inter-observer agreement was good for absolute sTILs (ICC 0.634, 95% CI 0.539-0.735, p < 0.001) but was poor to fair using binary cutpoints. sTILs heterogeneity was the main contributor to disagreement. When pathologists scored the same FOV from each case, inter-observer agreement was excellent for absolute sTILs (ICC 0.798, 95% CI 0.727-0.864, p < 0.001) and good for the 20% (ICC 0.657, 95% CI 0.561-0.756, p < 0.001) and 40% (ICC 0.644, 95% CI 0.546-0.745, p < 0.001) cutpoints. However, there was a wide range of scores for many cases. Reproducibility scoring sTILs is good when the scoring aid is used. Heterogeneity is the main contributor to variance and will need to be overcome for analytic validity to be achieved.

2nd Department of Pathology Semmelweis University Budapest Üllői út 93 1091 Budapest Hungary

Department of Clinical Pathology Sahlgrenska University Hospital 41345 Gothenburg Sweden

Department of Histopathology Cambridge University Hospitals National Health Service Foundation Trust Cambridge CB2 0QQ UK

Department of Medical Sciences University of Turin 10126 Turin Italy

Department of Pathology Bács Kiskun County Teaching Hospital 6000 Kecskemét Hungary

Department of Pathology Helsinki University Central Hospital 00029 Helsinki Finland

Department of Pathology Klinikum Donaustadt 1090 Vienna Austria

Department of Pathology Medical University of Vienna Währinger Gürtel 18 20 1090 Vienna Austria

Department of Pathology Riga Stradins University LV 1007 Riga Latvia

Department of Pathology School of Medicine University of Patras 26504 Rion Greece

Department of Surgical Pathology Zealand University Hospital 4000 Roskilde Denmark

Diagnostic and Research Institute of Pathology Medical University of Graz 8010 Graz Austria

Discipline of Pathology Lambe Institute for Translational Research School of Medicine National University of Ireland Galway H91 TK33 Galway Ireland

Division of Pathological Anatomy Department of Health Sciences University of Florence 50134 Florence Italy

Irish National Breast Screening Programme BreastCheck St Vincent's University Hospital D04 T6F4 Dublin Ireland

Laboratório de Anatomia Patológica Instituto Politécnico de Coimbra 3000 075 Coimbra Portugal

Laboratory of Translational Cell and Tissue Research Department of Imaging and Pathology University Hospitals Leuven 3000 Leuven Belgium

National Institute for Health Research Cambridge Biomedical Research Centre Cambridge CB2 0QQ UK

Pathology Department Herlev University Hospital DK 2730 Herlev Denmark

School of Mathematics Statistics and Applied Mathematics National University of Ireland Galway H91 TK33 Galway Ireland

School of Medicine University College Dublin D04 V1W8 Dublin Ireland

The Fingerland Department of Pathology Charles University Medical Faculty and University Hospital 50003 Hradec Kralove Czech Republic

Tumor Pathology Department Maria Sklodowska Curie National Research Institute of Oncology Gliwice Branch 44 102 Gliwice Poland

UDIAT Centre Diagnòstic Pathology Department Institut Universitari Parc Taulí UAB Parc Taulí 1 08205 Sabadell Spain

Unit of Anatomic Pathology Department of Biomedical and Neuromotor Sciences University of Bologna Bellaria Hospital 40139 Bologna Italy

Unit of Pathology Candiolo Cancer Institute FPO IRCCS 10060 Candiolo Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024037
003      
CZ-PrNML
005      
20211013134055.0
007      
ta
008      
211006s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers13174410 $2 doi
035    __
$a (PubMed)34503219
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kilmartin, Darren $u Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland
245    10
$a Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer / $c D. Kilmartin, M. O'Loughlin, X. Andreu, Z. Bagó-Horváth, S. Bianchi, E. Chmielik, G. Cserni, P. Figueiredo, G. Floris, MP. Foschini, A. Kovács, P. Heikkilä, J. Kulka, AV. Laenkholm, I. Liepniece-Karele, C. Marchiò, E. Provenzano, P. Regitnig, A. Reiner, A. Ryška, A. Sapino, E. Specht Stovgaard, C. Quinn, V. Zolota, M. Webber, D. Roshan, SA. Glynn, G. Callagy
520    9_
$a Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score cases in a reproducibility study. This study aimed to evaluate the reproducibility of sTILs assessment using this scoring aid in cases from routine practice and to explore the potential of the tool to overcome variability in scoring. Twenty-three breast pathologists scored sTILs in digitized slides of 49 TNBC biopsies using the scoring aid. Subsequently, fields of view (FOV) from each case were selected by one pathologist and scored by the group using the tool. Inter-observer agreement was good for absolute sTILs (ICC 0.634, 95% CI 0.539-0.735, p < 0.001) but was poor to fair using binary cutpoints. sTILs heterogeneity was the main contributor to disagreement. When pathologists scored the same FOV from each case, inter-observer agreement was excellent for absolute sTILs (ICC 0.798, 95% CI 0.727-0.864, p < 0.001) and good for the 20% (ICC 0.657, 95% CI 0.561-0.756, p < 0.001) and 40% (ICC 0.644, 95% CI 0.546-0.745, p < 0.001) cutpoints. However, there was a wide range of scores for many cases. Reproducibility scoring sTILs is good when the scoring aid is used. Heterogeneity is the main contributor to variance and will need to be overcome for analytic validity to be achieved.
655    _2
$a časopisecké články $7 D016428
700    1_
$a O'Loughlin, Mark $u Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland
700    1_
$a Andreu, Xavier $u UDIAT-Centre Diagnòstic, Pathology Department, Institut Universitari Parc Taulí-UAB, Parc Taulí, 1, 08205 Sabadell, Spain
700    1_
$a Bagó-Horváth, Zsuzsanna $u Department of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria
700    1_
$a Bianchi, Simonetta $u Division of Pathological Anatomy, Department of Health Sciences, University of Florence, 50134 Florence, Italy
700    1_
$a Chmielik, Ewa $u Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland
700    1_
$a Cserni, Gábor $u Department of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary
700    1_
$a Figueiredo, Paulo $u Laboratório de Anatomia Patológica, Instituto Politécnico de Coimbra, 3000-075 Coimbra, Portugal
700    1_
$a Floris, Giuseppe $u Laboratory of Translational Cell and Tissue Research, Department of Imaging and Pathology, University Hospitals Leuven, 3000 Leuven, Belgium
700    1_
$a Foschini, Maria Pia $u Unit of Anatomic Pathology, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bellaria Hospital, 40139 Bologna, Italy
700    1_
$a Kovács, Anikó $u Department of Clinical Pathology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden
700    1_
$a Heikkilä, Päivi $u Department of Pathology, Helsinki University Central Hospital, 00029 Helsinki, Finland
700    1_
$a Kulka, Janina $u 2nd Department of Pathology, Semmelweis University Budapest, Üllői út 93, 1091 Budapest, Hungary
700    1_
$a Laenkholm, Anne-Vibeke $u Department of Surgical Pathology, Zealand University Hospital, 4000 Roskilde, Denmark
700    1_
$a Liepniece-Karele, Inta $u Department of Pathology, Riga Stradins University, LV-1007 Riga, Latvia
700    1_
$a Marchiò, Caterina $u Unit of Pathology, Candiolo Cancer Institute FPO-IRCCS, 10060 Candiolo, Italy $u Department of Medical Sciences, University of Turin, 10126 Turin, Italy
700    1_
$a Provenzano, Elena $u Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge CB2 0QQ, UK $u National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK
700    1_
$a Regitnig, Peter $u Diagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria
700    1_
$a Reiner, Angelika $u Department of Pathology, Klinikum Donaustadt, 1090 Vienna, Austria
700    1_
$a Ryška, Aleš $u The Fingerland Department of Pathology, Charles University Medical Faculty and University Hospital, 50003 Hradec Kralove, Czech Republic
700    1_
$a Sapino, Anna $u Unit of Pathology, Candiolo Cancer Institute FPO-IRCCS, 10060 Candiolo, Italy $u Department of Medical Sciences, University of Turin, 10126 Turin, Italy
700    1_
$a Specht Stovgaard, Elisabeth $u Pathology Department, Herlev University Hospital, DK-2730 Herlev, Denmark
700    1_
$a Quinn, Cecily $u Irish National Breast Screening Programme, BreastCheck, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland $u School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland
700    1_
$a Zolota, Vasiliki $u Department of Pathology, School of Medicine, University of Patras, 26504 Rion, Greece
700    1_
$a Webber, Mark $u Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland
700    1_
$a Roshan, Davood $u School of Mathematics, Statistics and Applied Mathematics, National University of Ireland Galway, H91 TK33 Galway, Ireland
700    1_
$a Glynn, Sharon A $u Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland
700    1_
$a Callagy, Grace $u Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 13, č. 17 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34503219 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20211013134052 $b ABA008
999    __
$a ind $b bmc $g 1708171 $s 1144534
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 13 $c 17 $e 20210831 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
LZP    __
$a Pubmed-20211006

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...